trilostane has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beitz, AJ; Choi, HS; Choi, SR; Han, HJ; Kang, SY; Lee, JH; Roh, DH; Yoon, SY | 1 |
| Espallergues, J; Koseki, T; Laruelle, C; Mamiya, T; Maurice, T; Nabeshima, T; Temsamani, J; Vallée, M | 1 |
2 other study(ies) available for trilostane and Disease Models, Animal
| Article | Year |
|---|---|
Spinal cytochrome P450c17 plays a key role in the development of neuropathic mechanical allodynia: Involvement of astrocyte sigma-1 receptors.
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Astrocytes; Dihydrotestosterone; Disease Models, Animal; Hyperalgesia; Ketoconazole; Male; Mice; Mice, Inbred ICR; Neuralgia; Neurosteroids; Peripheral Nerve Injuries; Peripheral Nervous System Diseases; Receptors, sigma; Sciatic Nerve; Sigma-1 Receptor; Spinal Cord; Spinal Cord Dorsal Horn; Steroid 17-alpha-Hydroxylase | 2019 |
The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levels.
Topics: Adrenalectomy; Analysis of Variance; Animals; Anxiety, Castration; Biogenic Monoamines; Brain; Depression; Dihydrotestosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gas Chromatography-Mass Spectrometry; Male; Mice; Radioimmunoassay; Steroids; Swimming; Time Factors | 2012 |